Biolegend, 420801, Fixation Buffer, 100ml

Fixation Buffer is useful for intracellular staining procedures, e.g. , in preparation of cells for staining intracellular cytokines or other proteins. Fixation Buffer is used to fix cells prior to permeabilization using Permeabilization Wash Buffer (Cat. No. 421002). BioLegend's Fixation Buffer has been formulated with prescreened paraformaldehyde with low background, thus producing the greatest signal to noise ratio.
100ml
Storage & Handling: This buffer solution should be stored between 2°C and 8°C.
Application: ICFC - Quality tested ICC
Recommended Usage: For cell fixation, use 250 µL fixation buffer per tube and leave it in the dark for 20 minutes at room temperature. It is recommended that the reagent be titrated for optimal performance for each application. For the fixation procedure, please refer to the "Intracellular Cytokine Staining Protocol" under "Support" on BioLegend's website. Caution: This buffer contains paraformaldehyde, which is toxigenic and mutagenic. Please handle with caution and wear gloves, lab coat and necessary protection to avoid direct body contacts.
Application Notes: This 1X PBS solution contains 4% paraformaldehyde, which is toxic and is a suspected carcinogen. Contact with eyes, skin and mucous membranes should be avoided.
Additional Product Notes: View more applications data using this product to stain Veri-Cells™ lyophilized control cells and to perform phospho-flow in our Scientific Poster Library.
Application References(PubMed link indicates BioLegend citation): Kang YJ, et al. 2007. Nature Immunol. 8:601. Kenna TJ, et al. 2010. J. Immunol. 184:598. PubMed Sullivan BP, et al. 2010. Am J Pathol. 177:2837. PubMed del Rio ML, et al. 2011.Transplantation. 92:1085. PubMed del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed Haberthur K, et al. 2013. J Virol. 87:11751. PubMed Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
Product Citations: Haberthur K, et al. 2013. J Virol. 87:11751. PubMed Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed Wang H, et al. 2023. Nature. 615:339. PubMed Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed Deng G, et al. 2023. Cancers (Basel). 15:. PubMed Wang Y, et al. 2023. iScience. 26:106630. PubMed Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed Kim J, et al. 2021. Cytometry A. 99:807. PubMed Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed Mills EL, et al. 2022. Cell Metab. 34:140. PubMed Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed Madi A, et al. 2022. Int J Cancer. 151:797. PubMed Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed Noh J, et al. 2022. Cancers (Basel). 14: . PubMed Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed Chan L, et al. 2022. Cells. 12: . PubMed Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed Sun L, et al. 2023. Mol Med Rep. 27: . PubMed Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed Zander R, et al. 2022. Immunity. 55:475. PubMed Zhang H, et al. 2022. J Exp Med. 219:. PubMed Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed Spitzer SO, et al. 2019. Neuron. 101:459. PubMed Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed Li Q, et al. 2022. Cell Rep. 40:111308. PubMed Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed Zhang L, et al. 2021. J Immunol. 207:590. PubMed Li X, et al. 2022. Nat Commun. 13:2794. PubMed Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed Angiari S, et al. 2020. Cell Metab. 31:391. PubMed Garton J, et al. 2021. Immunohorizons. 5:802. PubMed Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed de Groot AE, et al. 2021. Prostate. 81:629. PubMed Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed van der Heide V, et al. 2022. Cell Rep. :110508. PubMed Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed Guye P, et al. 2016. Nat Commun. 7:10243. PubMed Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed Haryadi L, et al. 2019. Vet World. 12:1529. PubMed Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed Zhang X, et al. 2020. J Immunol. 205:1743. PubMed Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed Su W, et al. 2022. Front Immunol. 13:952338. PubMed Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed Zhang B, et al. 2022. J Exp Med. 219:. PubMed Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed Rada M, et al. 2021. Commun Biol. 4:950. PubMed Chakraborty S, et al. 2022. Sci Transl Med. . PubMed Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed Cho S, et al. 2017. Sci Rep. 7:35. PubMed Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed Balan I, et al. 2022. Front Immunol. 13:940095. PubMed Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed Wei W, et al. 2022. mSystems. 7:e0046922. PubMed Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed Yang J, et al. 2022. Microbiome. 10:149. PubMed Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed Yang B, et al. 2022. Bioengineered. 13:2685. PubMed Wang L, et al. 2020. EMBO J. 39:e104514. PubMed Liu X, et al. 2016. Sci Rep. 6:36722. PubMed Rio M, et al. 2012. J Immunol. 188:4885. PubMed Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed Rio M, et al. 2011. Transplantation. 92:1085. PubMed Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed Xu Q, et al. 2021. Theranostics. 11:1937. PubMed Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed Ma K, et al. 2022. iScience. 25:104347. PubMed Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed Wang Y, et al. 2020. Virol Sin. 36:122. PubMed Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed Kenna T, et al. 2010. J Immunol. 184:598. PubMed Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed Park SR, et al. 2020. Cell Rep. 32:108077. PubMed Woo MS, et al. 2021. J Exp Med. :218. PubMed Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed Zhao X, et al. 2022. iScience. 25:104690. PubMed Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed Labi V, et al. 2019. Genes Dev. 33:1673. PubMed Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed Huang T, et al. 2022. Nat Commun. 13:3489. PubMed Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed Witt G, et al. 2020. Cell Biol Toxicol. . PubMed Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed Sun Y, et al. 2022. iScience. 25:104846. PubMed Wang X, et al. 2022. Elife. 11:. PubMed Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed
Antigen References: 1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD). 2. Sander B, et al. 1991. Immunol. Rev. 119:65. 3. Sander B, et al. 1993. J. Immunol. Meth. 166:201. 4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.
Gene ID: NA
Regulatory Status: RUO
Other Names: Fixative, Paraformaldehyde